IJE Advance Access originally published online on December 8, 2005
International Journal of Epidemiology 2006 35(1):60-67; doi:10.1093/ije/dyi255
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Commentary |
Commentary: Understanding the epidemiology of overweight and obesitya real global public health concern
1 Department of Family and Community Medicine, Center on Social Disparities in Health, University of California, San Francisco, CA, USA
2 Department of Nutrition, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
* Corresponding author. Carolina Population Center, University of North Carolina, 123 W. Franklin Street, Chapel Hill, NC 27516, USA. E-mail: popkin{at}unc.edu
| Introduction |
|---|
|
|
|---|
Campos and his collaborators raise some useful and important questions about the way to understand the impact of overweight and obesity on health.1 Especially, bringing attention to some of the complexities in overweight/obesity and health relationships and covert financial interests involved in obesity research and related promotion activities is noteworthy. At the same time, however, they ignore some basic pathways linking dietary and physical activity patterns to weight dynamics to health. Furthermore, they selectively examine the literature and, as is easily done, arrive at the conclusion that there is much ado about nothing in the obesity epidemic or pandemic. A different reading of the way to study in a causal manner the role of these factors as they affect health provides us with a very different conclusion.
Rapidly changing diets and reduced physical activity levels have led to a marked increase in the prevalence of diet-related chronic diseases in both developed and developing countries.2,3 The pathway linking weight status to health is complex. Figure 1 provides a simplified view of the major research relating the key factors in this pathway. How one studies this pathway clearly affects one's conclusions. The manner in which obesity fits into this causal pathway and the methods for studying this are at the core of the discussion. Considerable progress in the scientific study of obesity's determinants and consequences has led to a growing understanding of the responsible causal pathways, risk factors, and mechanisms. In particular, there is now strong evidence relating dietary factors and physical activity levels to the risk of obesity, hypertension, certain cancers, diabetes, stroke, and other coronary heart disease (CHD).
|
Much of the debate with Campos et al. lies in their selective use of research on these pathways and misunderstanding of basic epidemiological principles. Clearly there are a large number of ways that diet directly affects the health outcomes noted in Figure 1 (pathways B1 and B3). The same is true for physical activity (pathways C2 and C3). An important thing to note is that some of these factors work through obesity (pathways B2, C1, D1, D2, and D3), as well as independently affect disease. Diabetes is a critical example. One of the foremost researchers in the diabetes world summarized some of the major relationships in two broad articles on the topic. In each he showed how increases in weight could directly affect diabetes independent of the physical activity effects. He then went on to show independent physical activity pathways.4,5 Later we review further literature on the obesity-disease topics but these overviews by Zimmet et al.5 provide some sense of the vast literature underlying each relationship and how a selective use of literature could miss the whole picture of the pathway and lead to a distorted conclusion.
There certainly are important issues raised by Campos et al.1some of which need careful review and do lead to areas where further research is needed. However, in contrast to their four main claims, our position is clear that increase in obesity and its health consequences are real, and the scientific community needs to provide more responsible solutions to this serious public health concern, instead of nullifying existing scientific evidence based on discriminatory use and fallacious interpretation of literature.
This article proceeds by discussing each of the points raised by Campos et al.1
| Global increases in weight are real! |
|---|
|
|
|---|
It is asserted that the weight increases are modest. What is implied is that weight increases are occurring in a small proportion of the population and these changes are small. On the one hand, many of Campos et al.'s inferences to insignificant weight change over time based on cross-sectional trend analyses at the population level reflect ecological fallacy.6 For example, their statement about the average American's weight gain explained by a few calories a day or a few minutes of walking could be very misleading, because average weight gain at the population level does not necessarily equate with weight gain at the individual level. The actual weight change of a population comprises a wide range of distributions. There may be a portion of the population who lose or do not change weight over time that would pull the mean weight change of the population down, which would make rather significant weight gains in some other groups of the population look trivial; ignoring these dynamics within a population may mask true changes that are happening among individuals. Also, what Campos et al.1 refer to as cessation of increase in weight based on the comparison of 19992000 and 200102 data is misleading, as it may simply be a reflection of sampling error, especially for population subgroups with relatively small sample size.7
In addition, what has been referred by Campos et al. as a subtle shift in BMI [body mass index or (weight in kilograms)/(height in meters)2] observed in the nationally representative data actually portends a remarkable increase in overweight/obesity. As the weight distribution shifts to the right, a greater proportion (the majority of people who belong to the centre of the distribution curve) of people enters into a higher range of BMI.
Data from around the world show radical increases in obesity.8,9 We suggest looking at available data that can explain some of the real shifts to assess the global epidemic of obesity. We begin with the example of China, utilizing unique longitudinal data on Chinese adults (2045 years old at baseline in 1989) from nine provinces.10 Our analysis shows that among adults, the weight change during the 11 year follow-up period (from 1989 to 2000) indeed has quite a wide distribution, and it is the majority of the people (73%) who gained weight (Figure 2). The average weight gain among those who gained weight during the follow-up period is 7.0 and 6.3 kg for men and women, respectively, uniformly across all baseline BMI categories. This is in contrast to Campos et al.'s first set of claims. Campos et al. in fact did not look at such longitudinal data to support their claims of a significant weight gain in only a minor portion of the people and people just crossing the border to become classified as overweight and obese compared with a generation ago.
|
This China example is important as it provides an example of the type of weight shifts we see in Mexico, many other South American countries, most Middle Eastern and South-east and East Asian countries.8
When we shift to higher income countries, there have been different types of shifts in the US and Russia and the few other more developed countries where overweight was very high. In these countries the increases in the past few decades are not as great in the normal weight category compared with the morbidly obesity categories. Among adults, in the US, the most profound is the large increase in the proportion of people with BMIs >35 and 40. Among US adolescents and children, however, the shifts have been across the BMI distribution and thus quite different from what has been observed among adults. Campos ignores these patterns.7,11,12
| Health consequences of obesity are real and serious! |
|---|
|
|
|---|
The recent two articles by CDC scholarsfirst Mokdad et al.13,14 cited death rates from obesity of 400 000 and then Flegal et al.15 showed 112 000 deathsreally created their own drama that most in the scholarly field dismissed. The death estimates from the first article were only partially adjusted for confounding factors. They also did not account for variation by age in the relation of body weight to mortality. The Flegal et al.15 study with its attribution of 112 000 deaths to obesity, while disputed for some questionable assumptions that might increase considerably the number of deaths, is well done and believable. What is important is that these are a lot of deaths but death probably does not describe the major health problems of obesity, which are morbidity, disability, hospitalization, and earlier entry to nursing homes. The quality of life is seriously compromised in obese individuals, but these health outcomes have only recently been measured and documented in depth. We discuss these issues later.
Campos is correct to note that the relationships between levels of obesity and overweight are very complex and the final answer on these relationships is not very clear.16 Definition of optimal BMI may need to be continuously challenged based on comprehensive scientific evidence. At the same time, they are wrong in stating the studies of obesity and mortality should control for dietary and activity patternsthe very factors that cause obesity. Just as you should not control for diabetes (a mediator in this case, which is critical to the causal chain, and will attenuate the association of the exposure with the outcome if treated as a confounder) in trying to understand how obesity affects mortality, one must not control for the underlying determinants of energy imbalance and obesity. Also, Campos et al.'s comment But the greatest problem with the statistical linkages between body mass and mortality is that other confounding factors are not considered, leaving little basis for drawing causal inferences shows poor understanding of epidemiological methods, as controlling multiple factors in analyses of observational studies does not convert non-experimental studies to experimental studies, from which only can we draw causal inferences.17
| Systematic reviews of the literature show clear links between obesity and adverse health and economic outcomes! |
|---|
|
|
|---|
Literature supporting increased morbidity in obese individuals is quite overwhelming. Epidemiological studies have shown the links between obesity and adverse health outcomes, and physiological mechanisms are provided to support these relationships. Overweight persons face not only the full array of health problems noted in Figure 1 but they also retire earlier, go at younger ages into nursing homes, have higher absenteeism rates, and are more likely to be disabled. Below we briefly summarize some of the major obesitymorbidity relationshipsdirect effect of obesity on a chronic health condition and further links between the health condition to other health issues, if present.
Hypertension: Increased blood pressure, as body weight increases, has been observed in both normotensive and hypertensive individuals. The pathogenesis of obesity-related hypertension is supported by the physiological mechanisms that leptin, free fatty acids, and insulinwhose levels are increased in obesitymay act individually and synergistically to stimulate sympathetic activity and vasoconstriction. In addition, obesity-induced insulin resistance and endothelial dysfunction may act as amplifiers of the vasoconstrictor response. Increased renal tubular re-absorption of sodium may also occur, caused by an increased renal sympathetic nerve activity, direct effect of insulin, hyperactivity of rennin-angiotensin system, and possibly by an alteration of intrarenal physical forces.18 Both obesity and hypertension predispose to cardiovascular morbidity and mortality.19 In turn, a history of hypertension is shown to increase the risk of type 2 diabetes independently of other known risk factors, including obesity.20 Elevated blood pressure is also a powerful risk factor for CHD and a significant predictor of mortality from strokefor men and women.21
Dyslipidaemia [imbalance in total, low-density lipoprotein (LDL) cholesterol, high-density lipoprotein (HDL) cholesterol, and triglycerides]: Obesity has been associated with increased levels of triglycerides and decreased HDL-cholesterol, both of which are independent risk factors for cardiovascular disease.22 Elevated levels of total cholesterol, LDL-cholesterol, and triglycerides are major risk factors for CHD in both men and women,23 whereas HDL levels are correlated inversely with the risk of CHD.24
Insulin resistance (glucose intolerance, impaired glucose tolerance, hyperinsulinaemia): Insulin resistance has been strongly associated with overweight and obesity in many epidemiological studies.25 Hyperinsulinaemia, in turn, is believed to increase the risk of colon cancer by directly promoting colon carcinogenesis and stimulating insulin-like growth factor-I receptors.17,26,27 A similar mechanism is provided for the case of endometrial cancer.28
Cancers:
- Colon cancer: Higher BMI is associated with increased risk for colon cancer, with the association stronger for larger adenomas and for men. These may suggest an effect of factors related to adiposity on the promotion of cancer and a possible counteracting effect on these factors by oestrogens.29
- Breast cancer: A contrasting pattern has been shown by menopausal status. Higher body weight, especially higher adult weight, is associated with increased breast cancer risk among post-menopausal women.29
- Oesophagus cancer: An increased incidence of gastric reflux in persons with high BMI has been proposed as the underlying cause of more than a 2-fold increase in the risk of oesophageal cancer.29
- Endometrium cancer: Convincing evidence from epidemiological studies shows a linear increase in the risk of endometrial cancer with increasing adult obesity.25,29 A hormonal mechanism is provided to support the association. Obese women have higher levels of serum oestrone and estradial, and decreased levels of sex hormone-binding globulin, both increasing the amount of bioavailable oestrogen. Elevated oestrogen levels stimulate endometrial epithelial cells, which is conducive to the development of cancer.30
- Kidney cancer: Studies conducted across nations consistently show a more than 2-fold increase in renal-cell cancer risk among obese (both men and women), compared with those of normal weight.29 Increased levels of endogenous oestrogens in women may affect renal cell proliferation and growth by receptors present in renal cells or through paracrine growth factors.31
In turn, remarkable similarity of risk factors for type 2 diabetes and colon cancer, coupled with a general hypothesis that hyperinsulinaemia increases the risk of colon cancer, has led to a theory that type 2 diabetes itself, is a risk factor for colon cancer; this association has been observed in epidemiological studies.33 Diabetes is also a risk factor for CHD and CHD accounts for much of the serious morbidity and a high proportion of the premature deaths in type 2 diabetes.34 Diabetic men and women have a 2- to 3-fold and 3- to 7-fold increase in risk of CHD, respectively, compared with their non-diabetic counterparts.35,36
Coronary heart disease (CHD): Obesity has been shown to be an independent risk factor for CHD in both men and women.37,38 In addition, as described above, obesity increases the risk of hypertension, dyslipidaemia, and diabetes mellitusall of which are risk factors for CHD.
Stroke: BMI is a strong risk factor for total and ischaemic stroke. The pathway from obesity to stroke is thought of as being developed through hypertension, diabetes, and elevated cholesterol.39
Gallbladder disease: Epidemiological studies have reported an association between gall bladder disease, overweight, and obesity.22 The pathogenesis of gall bladder disease involves numerous mechanisms that are present in obese individuals, such as excess hepatic secretion of cholesterol and subsequent supersaturation of bile, increased gall bladder volume, and blunted gall bladder contractility.40
Osteoarthritis: Being overweight increases the amount of force across a weight-bearing joint.41 In addition, adipose tissue may produce atypical hormone or growth factor concentrations that affect cartilage or underlying bone, predisposing them to osteoarthritis development.42
Further obesity affects Years of Disability Free Life and productivity, among others. Using the Original and Offspring Framingham Heart Study, Peeters et al.43 have again used the Years of Life concept to estimate the life expectancy for individuals, free of disability and classified by weight status. Disability was defined as limited mobility (i.e. limited walking on a level surface and walking up/down stairs) and limited activities of daily living (ADL) (i.e. limited dressing, grooming/bathing, feeding/eating, getting in and out of chairs). Among non-smokers, obese men had 5.70 (95% confidence interval (CI) 4.117.35) and obese women had 5.02 (95% CI 3.366.61) fewer years free of ADL limitations than normal weight counterparts. Regarding any mobility or ADL limitation, obese men had 6.02 (95% CI 4.357.61) and obese women had 5.53 (95% CI 3.767.34) fewer years free of limitation than normal weight counterparts. These researchers concluded, however, owing to the higher mortality in the obese and overweight groups, there was no significant difference in the years lived with disability (mobility or ADL limitation) between those overweight or obese and those with normal weight at baseline.
Minimal research has been conducted regarding the effect of obesity on the loss of productivity.4450 The research has examined loss of productivity in terms of disability or early retirement and days absent from work. The majority of this work was conducted in Scandinavian countries: Finland, Denmark, and Sweden.4448 Most of these studies (six of seven) have found obesity to be associated with disability or early retirement. One study examined sick leave histories and found an increased BMI to be associated with long-term sick leave.46 Another study conducted in the US found obesity to be associated with the combined outcome of limitations in the kind or amount of paid work, kind or amount of housework, and kind or amount of any activity.49 Finally, another study found obesity to be associated with days spent ill in bed; however, this association may vary depending on age.50
Scholars have studied the economic burden of obesity both in private and public sectors and found the costs to be considerable.5154 The major public payersMedicare and Medicaidfinance about half of these costs,53 so the costs of obesity are not borne just by the obese individuals and their families, but pose a significant externality on economic systems.
We could go on to review other ways obesity affects an individualnot only physically but also psychologicallyand society but stop here. The key issue is to point out that these effects are fairly consistent and profound. To state otherwise ignores a rather substantial literature to pick out a few self-selected references.
| Weight loss brings health benefits! |
|---|
|
|
|---|
Contrary to Campos et al.'s last claim, we find ample evidence that weight loss is beneficial in a number of health parameters and disease outcomes. This evidence, with numerous epidemiological findings, supports a causal link between weight and health. Weight loss, even a modest one, is shown to reduce or remove weight-related disorders in obese individuals55 such as type 2 diabetes,56 hyperlipidaemia,57 and hypertension.58 There is a direct link between what causes weight loss (i.e. improvement in diet and increased physical activity) and health benefits, but literature also shows an independent effect of weight loss on health56 and provides physiological mechanisms that support the effect of weight loss per se.55 Campos et al.1 again neglect to see the whole pathways.
Risks related to more aggressive methods of weight loss are real. This certainly brings an emphasis on primary prevention of overweight and obesity. Unless we stop the shift in weight now, public health challenges related to obesity that we are already facing now will grow even greater.
| Financial interests and the obesity epidemic |
|---|
|
|
|---|
The fact that many countries in all regions of the world have stated that obesity and its linkage with diabetes, heart disease, and stroke is utilizing excessive medical care facilities and represents a major health threat to its population points to the universality of the problem. Furthermore, it is clear that the news media, itself alarmed by the vast increase in overweight and obesity globally and the health consequences of this, has increased exponentially articles on the topic. This is only natural.
Campos et al.1 are correct that there are many with direct financial interests involved in research and promotion activities related to the obesity epidemic. On the one hand, there are organizations funded by the food industry pitted against all discussion of issues such as portion sizing, unhealthy or bad foods, excessive added sugar, excessive use of hydrogenated and saturated fats in the processed food industry, among others. On the other hand the drug industry has played a major role in funding several major international groups that attempt to promote programmes and knowledge related to obesity prevention and treatment. Similarly politics, particularly from the food industry, have affected all dietary guidance that emanates from the US Department of Agriculture. The US does not have free-standing independent organizations unfettered by the need to obtain funds that offer such guidance. There are few major organizations in any country except for groups such as the Center for Science in the Public Interest and a few others in higher income countries who could be said to be unfettered by funding from the food industry or the drug industry.
As with many scholars in the food, nutrition, and obesity research world, Popkin has taken gifts and contracts from the food industry to publish a range of studies in support of and against the various issues of concern to him academically. The authors received no funding for this specific article, but Popkin certainly has taken funding from many sources, which might have affected his judgement. The authors' integrity and that of our colleagues from the public health, economics, and medical professions can only be judged by what we write and state and how open we are on such funding and how active we are in trying to counteract such biases. The source of funding might have something to do with blaming the victim vs blaming the environment. With the other 97% of all research funding coming from NIH, Popkin is much more able to blame the food and activity environment for many of the underlying causes of poor dietary and activity patterns. At the same time others who are equally independent do not feel this way so to state that source of funding is the cause of who blames the victim and who does not is a bit naïve. The food industry has been most likely to blame physical activity and the victim of poor eating decisions and call for freedom of choice. Clearly this comes from self-interest but Campos et al. did not talk about such self-interests.
We do know that physical activity patterns and dietary patterns have changed. We cannot fully ascribe how much of the increased energy intake comes from portion sizing, energy density, added sweeteners in the diet, and so on. All of these factors appear important. Nor can we ascribe how much of the reduced energy expenditure comes from reductions in activity at occupational activity, housework, transportation, and leisure.
| Discussion |
|---|
|
|
|---|
To state that the obesity increase is an illusion and that increased weight and adiposity does not contribute to poor health and functioning is really to misuse the vast literature that shows the large increases in weight and BMI dynamics globally3,8,9,59 and also the important effects of these changes on global disease profiles.60
Campos et al. neglect that by falsely invalidating existing evidence of increasing obesity and its health impact, they further harm the most vulnerable subgroups in the populations; it is often the poor, people with lower socioeconomic status, and some socially disadvantaged racial/ethnic groups that disproportionately suffer from the obesity epidemic,7,61 both adults and children alike.62 When the alarming increases in weight nationally and globally are ignored, these already marginalized and stigmatized subgroups, socially and health-wise, will suffer even greater from obesity-related morbidity and mortality. We feel that treating a real health problem as non-existing is equally irresponsible as blaming the victims only.
The reality is that obesity is generated by lifestyle behaviours that are largely affected by the environment in which people live.63 Unless our environments are not altered to promote healthy living, the increasing weight will continue to grow, and so will obesity-related morbidity and mortality. Providing freedom to choose unhealthy lifestyles that will lead to obesity and related health problems is not what a healthy society should do. We encourage the scientific community to join in the efforts to create more responsible solutions for the obesity epidemic at the societal level, rather than denying the problem or being swayed by parties whose number one priority is not necessarily improving public health.
| Acknowledgments |
|---|
We thank the NIH (R01-HD30880, R01-HD38700; R01-HD39183 R01 HD041375 and P30ES10126) and W.K. Kellogg Scholars in Health Disparities Program for financial support to be able to perform the analysis. We also wish to thank Ms Frances L. Dancy for administrative assistance, Mr Tom Swasey for graphics support, and Ms Keri Monda for research assistance. None of the authors has conflict of interests of any type with respect to this manuscript.
| References |
|---|
|
|
|---|
1 Campos JD, Saguy A, Ernsberger P, Oliver E, Gaesser G. The epidemiology of overweight and obesity: Public health crisis or moral panic? Int J Epidemiol 2006;35:5560.
2 Popkin BM. The nutrition transition and its health implications in lower income countries. Public Health Nutr 1998;1:521.[CrossRef][Medline]
3 Popkin BM. The nutrition transition in the developing world. Dev Policy Rev 2003;21:58197.[CrossRef]
4 Zimmet PZ. Kelly West Lecture. Challenges in diabetes epidemiologyfrom west to the rest. Diabetes Care 1991;15:23252.
5 Zimmet PZ, McCarty DJ, de Courten MP. The global epidemiology of non-insulin-dependent diabetes mellitus and the metabolic syndrome. J Diabetes Complicat 1997;11:6068.[CrossRef][Web of Science][Medline]
6 Greenland S, Robins J. Invited commentary: ecologic studiesbiases, misconceptions, and counterexamples. Am J Epidemiol 1994;139:74760.
7 Hedley AA, Ogden CL, Johnson CL, Carroll MD, Curtin LR, Flegal KM. Prevalence of overweight and obesity among US children, adolescents, and adults, 19992002. JAMA 2004;291:284750.
8 Mendez MA, Monteiro CA, Popkin BM. Overweight now exceeds underweight among women in most developing countries! Am J Clin Nutr 2005;81:71421.
9 Popkin BM. An overview on the nutrition transition and its health implications: the Bellagio meeting. Public Health Nutr 2002;5:93103.
10 Du S, Mroz TA, Zhai F, Popkin BM. Rapid income growth adversely affects diet quality in Chinaparticularly for the poor? Soc Sci Med 2004;59:150515.
11 Troiano RP, Flegal KM, Kuzmarski RJ, Campbell SM, Johnson CL. Overweight prevalence and trends for children and adolescents. Arch Pediatr Adolesc Med 1995;149:108591.
12 Wang Y, Monteiro C, Popkin BM. Trends of overweight and underweight in children and adolescents in the United States, Brazil, China, and Russia. Am J Clin Nutr 2002;75:97177.
13 Mokdad AH, Marks JS, Stroup DF, Gerberding JL. Actual causes of death in the United States, 2000 JAMA 2004;291:123845.
14 Mokdad AH, Marks JS, Stroup DF, Geberding JL. Correction: actual causes of death in the United States, 2000. JAMA 2005;293:29394.
15 Flegal KM, Graubard BI, Williamson DF, Gail MH. Excess deaths associated with underweight, overweight, and obesity. JAMA 2005;293:186167.
16 Stevens J, Cai J, Pamuk ER, Williamson DF, Thun MJ, Wood JL. The effect of age on the association between body-mass index and mortality. N Engl J Med 1998;338:17.
17 Christenfeld NJ, Sloan RP, Carroll D, Greenland S. Risk factors, confounding, and the illusion of statistical control. Psychosom Med 2004;66:86875.
18 Montani JP, Antic V, Yang Z, Dulloo A. Pathways from obesity to hypertension: from the perspective of a vicious triangle. Int J Obes 2002;26 (Suppl. 2): S28S38.[Web of Science]
19 Wolk R, Shamsuzzaman ASM, Somers VK. Obesity, sleep apnea, and hypertension. Hypertension 2003;42:106774.
20 Helmrich SP, Ragland DR, Leung RW, Paffenbarger RS. Physical activity and reduced occurrence of non-insulin-dependent diabetes mellitus. N Engl J Med 1991;325:14752.[Abstract]
21 Antikainen R, Jousilahti P, Tuomilehto J. Systolic blood pressure, isolated systolic hypertension and risk of coronary heart disease, strokes, cardiovascular disease and all-cause mortality in the middle-aged population. J Hypertens 1998;16:57783.[CrossRef][Web of Science][Medline]
22 Pi-Sunyer FX. Comorbidities of overweight and obesity: current evidence and research issues. Med Sci Sports Exerc 1999;31 (Suppl. 11): S60208.[Web of Science][Medline]
23 Coleman MP, Key TJA, Wang DY et al. A prospective study of obesity, lipids, apolipoproteins and ischaemic heart disease in women. Atherosclerosis 1992;92:17785.[CrossRef][Web of Science][Medline]
24 Gordon DJ, Probstifield JL, Garrison RJ et al. High-density lipoprotein cholesterol and cardiovascular disease: four prospective American studies. Circulation 1989;79:815.
25 Lipton RB, Liao Y, Cao G, Cooper RS, McGee D. Determinants of incident non-insulin-dependent diabetes mellitus among blacks and whites in a national sample: the NHANES I Epidemiologic Follow-Up Study. Am J Epidemiol 1993;138:82639.
26 Giovannucci E. Insulin and colon cancer. Cancer Causes Control 1995;6:16479.[CrossRef][Web of Science][Medline]
27 Schoen RE, Tangen CM, Kuller LH et al. Increased blood glucose and insulin, body size and incident colorectal cancer. J Natl Cancer Inst 1999;91:114754.
28 Kaaks R, Lukanova A, Kurzer MS. Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review. Cancer Epidemiol Biomarkers Prev 2002;11:153143.
29 IARC Working Group. IARC Working Group on the evaluation of cancer-preventive strategies. In: Vanio H, Bianchini F (eds). IARC Handbooks of Cancer Prevention, Vol. 6. Weight Control and Physical Activity. Lyon, France: IARC Press, 2002.
30 Carroll KK. Obesity as a risk factor for certain types of cancer. Lipids 1998;33:105559.[Web of Science][Medline]
31 Wolk A, Lindblad P, Adami HO. Nutrition and renal cell cancer. Cancer Causes Control 1996;7:518.[CrossRef][Web of Science][Medline]
32 Colditz GA, Willett WC, Stampfer MJ et al. Weight as a risk factor for clinical diabetes in women. Am J Epidemiol 1990b;132:50113.
33 Hu FB, Manson JE, Liu S et al. Prospective study of adult onset diabetes mellitus (type 2) and risk of colorectal cancer in women. J Natl Cancer Inst 1999;91:54247.
34 Mann JI. Diet and risk of coronary heart disease and type 2 diabetes. Lancet 2002;360:78389.[CrossRef][Web of Science][Medline]
35 Bonow RO, Bohannon N, Hazzard W. Risk stratification in coronary artery disease and special populations. Am J Med 1996;101:4A17S22S.[Medline]
36 Seeman T, Mendes de LC, Berkman L, Ostfeld A. Risk factors for coronary heart disease among older men and women: a prospective study of community-dwelling elderly. Am J Epidemiol 1993;138:103749.
37 Willett WC, Manson JE, Stampfer MJ et al. Weight, weight change, and coronary heart disease in women: Risk within the normal weight range. JAMA 1995;273:46165.
38 Manson JE, Colditz GA, Stampfer MJ et al. A prospective study of obesity and risk of coronary heart disease in women. N Engl J Med 1990;322:88289.[Abstract]
39 Kurth T, Gaziano JM, Rexrode KM et al. Prospective study of body mass index and risk of stroke in apparently healthy women. Circulation 2005;111:199298.
40 Dittrick GW, Thompson JS, Campos D, Bremers D, Sudan D. Gallbladder pathology in morbid obesity. Obes Surg 2005;15:23842.[Medline]
41 Syed IY, Davis BL. Obesity and osteoarthritis of the knew: hypotheses concerning the relationship between ground reaction forces and quadriceps fatigue in long-duration walking. Med Hypotheses 2000;54:18285.[CrossRef][Web of Science][Medline]
42 Sowers M. Epidemiology of risk factors for osteoarthritis: systemic factors. Curr Opin Rheumatol 2001;13:44751.[CrossRef][Web of Science][Medline]
43 Peeters A, Bonneux L, Nusselder WJ, De Laet C, Barendregt JJ. Adult obesity and the burden of disability throughout life. Obes Res 2004;12:114551.[Web of Science][Medline]
44 Rissanen A, Heliovaara M, Knekt P, Reunanen A, Aromaa A, Maatela J. Risk of disability and mortality due to overweight in a Finnish population. Br Med J 1990;301:83537.
45 Krause N, Lynch J, Kaplan GA, Cohen RD, Goldberg DE, Salonen JT. Predictors of disability retirement. Scand J Work Environ Health 1997;23:40313.[Web of Science][Medline]
46 Narbro K, Jonsson E, Larsson B, Waaler H, Wedel H, Sjostrom L. Economic consequences of sick-leave and early retirement in obese Swedish women. Int J Obes 1996;20:895903.
47 Biering-Sorensen F, Lund J, Hoydalsmo OJ et al. Risk indicators of disability pensiona 15 year follow-up study. Danish Med Bull 1999;46:25862.
48 Mansson NO, Eriksson KF, Israelsson B, Ranstam J, Melander A, Rastam L. Body mass index and disability pension in middle-aged mennon-linear relations. Int J Epidemiol 1996;25:8085.
49 Ostermann J, Sloan FA. Effects of alcohol consumption on disability among the near elderly: a longitudinal analysis. Milbank Q 2001;79:487515.[CrossRef][Web of Science][Medline]
50 Ferraro KF, Booth TL. Age, body mass index, and functional illness. J Gerontol B Psychol Sci Soc Sci 1999;54B: S33948.[Abstract]
51 Wolf AM, Colditz GA. Current estimates of the economic costs of obesity in the United States. Obes Res 1998;6:97.[Web of Science][Medline]
52 Thompson D, Wolf AM. The medical-care cost burden of obesity. Obes Rev 2001;2:18997.[CrossRef][Medline]
53 Finkelstein EA, Fiebelkorn IC, Wang G. National medical spending attributable to overweight and obesity, how much, and who's paying? Health Affairs 2003; S3:21926.
54 Quesenberry CP Jr, Caan B, Jacobson A. Obesity, health services use, and health care costs among members of a health maintenance organization. Arch Intern Med 1998;158:46672.
55 Pasanisi F, Contaldo F, de Simone G, Mancini M. Benefits of sustained moderate weight loss in obesity. Nutr Metab Cardiovasc Dis 2001;11:40106.[Web of Science][Medline]
56 Wensier RL, James LD, Darnell BE et al. Lipid and insulin concentrations in obese postmenopausal women: separate effects of energy ventilation and weight loss. Am J Clin Nutr 1992;56:4449.
57 Dattilo AM, Kris-Etherton PM. Effects of weight reduction on blood lipids and lipoproteins: a meta-analysis. Am J Clin Nutr 1992;56:32028.
58 The Trials of Hypertension Prevention Collaborative Research Group. The effects of non pharmacological interventions on blood pressure or persons with high to normal levels: results of the Trials of Hypertension Prevention. JAMA 1992;267:121320.
59 Monteiro CA, Conde WL, Lu B, Popkin BM. Obesity and inequities in health in the developing world. Int J Obes 2004;28:118186.
60 Joint WHO/FAO Expert Consultation on diet, nutrition and the prevention of chronic diseases, diet, nutrition and the prevention of chronic diseases: report of a joint WHO/FAO expert consultation. Geneva, Switzerland: WHO, 2003.
61 Denney JT, Krueger PM, Rogers RG, Boardman JD. Race/ethnic and sex differentials in body mass among US adults. Ethn Dis 2004;14:38998.[Medline]
62 Ritchie LD, Ivey SL, Woodward-Lopez G, Crawford PB. Alarming trends in pediatric overweight in the United States. Soz Praventivmed 2003;48:16877.[Web of Science][Medline]
63 French SA, Story M, Jeffery RW. Environmental influences on eating and physical activity. Ann Rev Public Health 2001;22:30935.[CrossRef][Web of Science][Medline]
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
C. E. Lewis, K. M. McTigue, L. E. Burke, P. Poirier, R. H. Eckel, B. V. Howard, D. B. Allison, S. Kumanyika, and F. X. Pi-Sunyer Mortality, Health Outcomes, and Body Mass Index in the Overweight Range: A Science Advisory From the American Heart Association Circulation, June 30, 2009; 119(25): 3263 - 3271. [Full Text] [PDF] |
||||
![]() |
C. E. Landhuis, R. Poulton, D. Welch, and R. J. Hancox Childhood Sleep Time and Long-Term Risk for Obesity: A 32-Year Prospective Birth Cohort Study Pediatrics, November 1, 2008; 122(5): 955 - 960. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Mejean, P. Traissac, S. Eymard-Duvernay, J. El Ati, F. Delpeuch, and B. Maire Diet Quality of North African Migrants in France Partly Explains Their Lower Prevalence of Diet-Related Chronic Conditions Relative to Their Native French Peers J. Nutr., September 1, 2007; 137(9): 2106 - 2113. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. D. Gardner, A. Kiazand, S. Alhassan, S. Kim, R. S. Stafford, R. R. Balise, H. C. Kraemer, and A. C. King Comparison of the Atkins, Zone, Ornish, and LEARN Diets for Change in Weight and Related Risk Factors Among Overweight Premenopausal Women: The A TO Z Weight Loss Study: A Randomized Trial JAMA, March 7, 2007; 297(9): 969 - 977. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Koutsari and M. D. Jensen Thematic review series: Patient-Oriented Research. Free fatty acid metabolism in human obesity J. Lipid Res., August 1, 2006; 47(8): 1643 - 1650. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ebrahim Obesity, fat, and public health Int. J. Epidemiol., February 1, 2006; 35(1): 1 - 2. [Full Text] [PDF] |
||||
![]() |
P. Campos, A. Saguy, P. Ernsberger, E. Oliver, and G. Gaesser Response: lifestyle not weight should be the primary target Int. J. Epidemiol., February 1, 2006; 35(1): 81 - 82. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||







